Press Release
Cellnovo announces its 2017 financial calendar Paris, France, November 7, 2016 - Cellnovo Group ("Cellnovo" CLNV: EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, today publishes its financial calendar for the year 2017.Events | Date * |
2016 FY sales | Tuesday, January 31, 2017 |
2016 FY results and 2017 Q1 sales | Wednesday, April 26, 2017 |
Shareholders' meeting | Thursday, June 22, 2017 |
2017 H1 sales | Tuesday, July 25, 2017 |
2017 H1 results | Wednesday, September 27, 2017 |
2017 Q3 sales | Tuesday, October 31, 2017 |
* Subject to modification. Press releases are published after market closes.
About CellnovoAn independent medical technology company specialising in diabetes, Cellnovo has developed and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Compact, tubeless, intuitive and entirely connected, Cellnovo's insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient's condition to be continually monitored by family members and healthcare professionals in real time.
For further information please visit www.cellnovo.com
About the Cellnovo Diabetes Management SystemCompact, tubeless, intuitive and entirely connected, Cellnovo's insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections with drop-by-drop precision, whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient's condition to be continually monitored by family members and healthcare professionals in real time.
ContactCellnovo Chief Executive Officer Sophie Baratte investors@cellnovo.com | NewCap Investor Relations Tristan Roquet Montégon + 33 1 44 71 00 16 Media Relations in France Nicolas Merigeau + 33 1 44 71 94 98 cellnovo@newcap.eu | Consilium Strategic Communications Media Relations in United Kingdom Chris Gardner, Chris Welsh, Laura Thornton +44 20 3709 5700 cellnovo@consilium.com |
Cellnovo is listed on Euronext, Compartment C
ISIN: FR0012633360 - Ticker: CLNV
Cellnovo SA published this content on 07 November 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 November 2016 20:25:04 UTC.
Original documenthttp://cdn2.hubspot.net/hubfs/1775161/Press_releases/PDF-PRESS-RELEASES/07.November2016/Cellnovo_PR_Calendar_04112016 clean.pdf?t=1479993605358
Public permalinkhttp://www.publicnow.com/view/2B5238E72563DA41CFD23EDD75FAD31C763AC00C